Bone complications are an important determinant of the quality of life of patients with Gaucher disease [1]; as skeletal involvement does not always correlate with the severity of organ involvement, careful monitoring of this compartment is imperative. The reported percentage of patients with bone involvement varies based on its definition; for example, an International Gaucher Disease Registry report by Charrow et al. established that 706 out of 755 (94%) patients had radiologic evidence of one or more manifestations of bone disease, yet 361 out of 512 (71%) patients had a history of severe radiologic bone disease [2]. The prevention of bone complications is an important goal of treatment of patients with Gaucher disease. Bone complication...
Gaucher disease is a rare autosomal recessive disorder of glycosphingolipid metabolism resulting fro...
Gaucher disease is a rare autosomal recessive disorder of glycosphingolipid metabolism resulting fro...
Enzyme replacement therapy (ERT) for Gaucher disease with mannose-terminated glucocerebrosidase has ...
Bone complications are an important determinant of the quality of life of patients with Gaucher dise...
Bone involvement can represent the inaugural symptom of Gaucher's disease (GD). Here, we report the ...
Gaucher disease is characterized by multi-organ infiltration of phospholipid-laden macrophages. Bone...
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation and dysfunc...
Gaucher disease is a relatively rare metabolic disease caused by the inherited deficiency of the lys...
Gaucher disease is a relatively rare metabolic disease caused by the inherited deficiency of the lys...
Aim:Gaucher disease (GD) is the most prevalent hereditary lysosomal storage disorder, affecting mult...
Gaucher’s disease is a rare inherited lysosomal storage disease due to a genetic deficiency of an en...
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation and dysfunc...
Gaucher disease (GD) is a lysosomal storage disorder characterized by accumulation of glucosylcerami...
Objective: This study aimed to assess osteopenia and trabeculation loss in the jaws of patients diag...
Gaucher disease type 1 (GD1) is a rare inherited disease caused by mutations in the GBA1 gene, which...
Gaucher disease is a rare autosomal recessive disorder of glycosphingolipid metabolism resulting fro...
Gaucher disease is a rare autosomal recessive disorder of glycosphingolipid metabolism resulting fro...
Enzyme replacement therapy (ERT) for Gaucher disease with mannose-terminated glucocerebrosidase has ...
Bone complications are an important determinant of the quality of life of patients with Gaucher dise...
Bone involvement can represent the inaugural symptom of Gaucher's disease (GD). Here, we report the ...
Gaucher disease is characterized by multi-organ infiltration of phospholipid-laden macrophages. Bone...
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation and dysfunc...
Gaucher disease is a relatively rare metabolic disease caused by the inherited deficiency of the lys...
Gaucher disease is a relatively rare metabolic disease caused by the inherited deficiency of the lys...
Aim:Gaucher disease (GD) is the most prevalent hereditary lysosomal storage disorder, affecting mult...
Gaucher’s disease is a rare inherited lysosomal storage disease due to a genetic deficiency of an en...
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation and dysfunc...
Gaucher disease (GD) is a lysosomal storage disorder characterized by accumulation of glucosylcerami...
Objective: This study aimed to assess osteopenia and trabeculation loss in the jaws of patients diag...
Gaucher disease type 1 (GD1) is a rare inherited disease caused by mutations in the GBA1 gene, which...
Gaucher disease is a rare autosomal recessive disorder of glycosphingolipid metabolism resulting fro...
Gaucher disease is a rare autosomal recessive disorder of glycosphingolipid metabolism resulting fro...
Enzyme replacement therapy (ERT) for Gaucher disease with mannose-terminated glucocerebrosidase has ...